Over 30 Billion dollars in trust fund money has been set aside for asbestos victims.
Get a Free copy of Surviving Mesothelioma, Lean on Me, or 100 Questions & Answers About Mesothelioma
Mesolink.org now offeres Free Assistance with VA Claims and other benefits.
Contact Information
The Purdue Center for Cancer Research supports multiple disciplines of cancer research. The Center’s goal is to determine the best response to cancer growth in a human individual. Cancer research ranges from:
The facility is located in West Lafayette, Indiana. Shortly after President Nixon announced his war on cancer in 1971, the Purdue Center for Cancer Research received a planning grant from the National Cancer Institute (NCI) that funded the inception of the center. The grant was awarded in 1976.
In 1978, the center received more funding from the National Cancer Institute for support. This grant was deemed the Core Grant. The Purdue Center for Cancer Research continues to renew the Core Grant and has received six renewals from the National Cancer Institute. The Purdue University Cancer Center has conducted cancer research longer than most clinics and received its designation as a Cancer Center in 1978. Additionally, the Oncological Sciences Center at Discovery Park opened in 2005; The Purdue Cancer Center partners with this center to develop leading edge cancer drugs. In 2009, the center officially adopted the name Purdue University Center for Cancer Research.
Research scientists at this facility serve as academic faculty in addition to conducting research. Currently, 77 members are a part of the expansive research team. Recently, Purdue’s Oncological Sciences Center and Indiana University’s Melvin and Bren Simon Cancer Center joined forces to share a five-year, $1 million grant. The Walther Cancer Foundation is providing the grant to promote cancer research advancements, and this grant is just $1 million of nearly $100 million that the Walther Cancer Foundation has donated since 1985.
The Regenstrief Foundation and the Walther Foundation are also providing funding for the the Cancer Care Engineering project. The program will utilize principles of engineering to study the behavior of cancer cells through statistical modeling and other technology. The goal of the project is to improve cancer treatment, diagnostic tools, and cancer prevention.
The Purdue Cancer Center has partnered with the National Cancer Institute to provide patients with information regarding clinical trials in the area. Several leading oncologists conduct clinical trials in the state of Indiana; Dr. Laurence Bates, M.D., Anita Conte, M.D., Michael Slaughter, M.D., and Randall Trowbridge M.D. each conduct clinical trials for leading edge cancer treatments and diagnostic testing.
Research in the area of immunology is also being conducted at Purdue University Cancer Center. Marietta Harrison studies the beginning stages of the immune system's response to determine how the body attacks cancer once it develops. She is expounding upon studies in nanotechnology, drug care, and cancer care in order to develop more effective cancer therapies.
Studies are being conducted in the area of diagnostic testing tools, specifically imaging technology. New technologies include “Smart” MR probes and Magnetic Resonance Imaging. Imaging tools are used to identify the size and location of tumors within the body. They are also used to monitor tumor development after drugs have been administered in the body.
Research funds are continually being solicited for cancer research. The research at Purdue Cancer Center is varied ranging from technological research to genetic research. The James R. Lowe grant provides some funding for lung cancer research. Patients suffering from rare cancer diseases such as mesothelioma, may find research funds allocated towards the development of treatments.